Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Ormandy

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Plos Genetics|January 3, 2020
ELF5 modulates the estrogen receptor cistrome in breast cancerCatherine L Piggin, Daniel L Roden, Andrew M K Law, et al.
Plos Genetics|October 27, 2015
HENMT1 and piRNA Stability Are Required for Adult Male Germ Cell Transposon Repression and to Define the Spermatogenic Program in the MouseShu Ly Lim, Zhi Peng Qu, R Daniel Kortschak, et al.
Iscience|February 8, 2021
Inhibitor of Differentiation 4 (ID4) represses mammary myoepithelial differentiation via inhibition of HEBHolly Holliday, Daniel Roden, Simon Junankar, et al.
The EMBO Journal|January 15, 2005
Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactationJiong Zhou, Renee Chehab, Josephine Tkalcevic, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 21, 2006
c-Myc overexpression and endocrine resistance in breast cancerCatriona M McNeil, C Marcelo Sergio, Luke R Anderson, et al.
Oncogene|November 19, 2019
MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinomaLesley Castillo, Adelaide I J Young, Amanda Mawson, et al.
Oncotarget|September 28, 2014
Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic diseaseHeidi N Hilton, Tram B Doan, J Dinny Graham, et al.
Histopathology|May 13, 2010
High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtypeSarah J Zardawi, Ibrahim Zardawi, Catriona M McNeil, et al.
Breast Cancer Research : BCR|December 10, 2016
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinibAdelaide I J Young, Andrew M K Law, Lesley Castillo, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Plos Genetics|January 3, 2020
ELF5 modulates the estrogen receptor cistrome in breast cancerCatherine L Piggin, Daniel L Roden, Andrew M K Law, et al.
Plos Genetics|October 27, 2015
HENMT1 and piRNA Stability Are Required for Adult Male Germ Cell Transposon Repression and to Define the Spermatogenic Program in the MouseShu Ly Lim, Zhi Peng Qu, R Daniel Kortschak, et al.
Iscience|February 8, 2021
Inhibitor of Differentiation 4 (ID4) represses mammary myoepithelial differentiation via inhibition of HEBHolly Holliday, Daniel Roden, Simon Junankar, et al.
The EMBO Journal|January 15, 2005
Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactationJiong Zhou, Renee Chehab, Josephine Tkalcevic, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 21, 2006
c-Myc overexpression and endocrine resistance in breast cancerCatriona M McNeil, C Marcelo Sergio, Luke R Anderson, et al.
Oncogene|November 19, 2019
MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinomaLesley Castillo, Adelaide I J Young, Amanda Mawson, et al.
Oncotarget|September 28, 2014
Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic diseaseHeidi N Hilton, Tram B Doan, J Dinny Graham, et al.
Histopathology|May 13, 2010
High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtypeSarah J Zardawi, Ibrahim Zardawi, Catriona M McNeil, et al.
Breast Cancer Research : BCR|December 10, 2016
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinibAdelaide I J Young, Andrew M K Law, Lesley Castillo, et al.
Pageof 8